| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb141b396e502bfce986c491d722e401 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-10043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-16 |
| filingDate |
2006-11-09^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97c6510e80977885651e39bbd79769a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5580562bf94703a9fbc297436913f88 |
| publicationDate |
2008-08-29^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20080079243-A |
| titleOfInvention |
HCC-reactive T cell receptor |
| abstract |
The present invention provides cells expressing HCV epitope-reactive recombinant T cell receptors useful for the treatment and / or prevention of acute or chronic HCV and HCV-related symptoms or malignancies. The invention further provides methods of making HCV epitope reactive T cell receptors and therapeutic methods using cells expressing HCV epitope reactive recombinant T cell receptors. Provided are polynucleotides, constructs and vectors encoding HCV epitope reactive recombinant T cell receptors. |
| priorityDate |
2005-11-10^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |